Skip to main content
Hit enter to search or ESC to close
Immunogenicity and safety of a booster vaccination with a recombinant protein RBD fusion dimer candidate (PHH-1V) againts SARS-COV-2 in adults fully vaccinated againts COVID-19
© 2022 VHIR Annual Report 2021.
Six Top Stories
Facts & Figures
Partners and Acknowledgements
VHIR Annual Report 2021